- Cullen L. et. al. 2024 Study Published in the European Heart Journal
- Pickering J. et. al. 2024 Study Published in the Emergency Medicine Journal
- Zalama-S谩nchez et al. 2024 Article, Journal of Personalized Medicine
- De luliis et al. 2024 Article, Clin Chem Lab Med.
- Pickering JW et al. 2024 Article, Eur Heart J Acute Cardiovasc Care
- Florkowski et al. 2024 Article, Clin Chem Lab Med
Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h
Authors: Cullen L., Apple F., et. al.
2024 Study Published in the European Heart Journal
New international multicenter study showcasing the impact of the Atellica庐 VTLi high-sensitivity troponin I (hs-cTnI) assay in the emergency assessment of patients with suspected acute myocardial infarction (AMI).
Determination of a wholeblood single-test low-risk threshold for a point-of-care high-sensitivity troponin assay
Authors: Pickering J., Than M., et.al.
2024 Study Published in the Emergency Medicine Journal
To enhance care delivery in emergency departments (EDs) through faster risk-stratification methods, this study showcases initial findings from the ICare-FASTER interventional clinical trial. Focusing on point-of-care technology within an Accelerated Diagnostic algorithm (0-2 h), it discusses the clinical utilization of this algorithm conducted at Christchurch Hospital in New Zealand and highlights its impact on reducinTo enhance care delivery in emergency departments (EDs) through faster risk-stratification methods, this study showcases initial findings from the ICare-FASTER interventional clinical trial. Focusing on point-of-care technology within an Accelerated Diagnostic algorithm (0-2 h), it discusses the clinical utilization of this algorithm conducted at Christchurch Hospital in New Zealand and highlights its impact on reducing the overall length of stay for patients.
Diagnostic Performance of Point-of-Care High-Sensitivity Troponin in the Exclusion of Non-ST-Elevation of Myocardial Infarction in the Emergency Department
Daniel Zalama-S谩nchez, et al.
2024 Article, Journal of Personalized Medicine
Independent, multicenter, observational, prospective, noninterventional study conducted for 7 months (June鈥揇ecember 2023) in two Spanish hospitals (Hospital Cl铆nico Universitario de Valladolid [HCUV] and Hospital Universitario Rio Hortega [HURH].
Diagnostic performance of a point of care high-sensitivity cardiac troponin I assay and single measurement evaluation to rule out and rule in acute coronary syndrome
De luliis et al.
2024 Article, Clin Chem Lab Med.
Independent, prospective, observational study that evaluates diagnostic performance of POC Atellica庐 VTLi hs-cTnI system in a real-world setting in 966 chest pain patients consecutively enrolled July 2022 to June 2023 at G Mazzini Hospital, Teramo, Italy
iCare Faster 8 Week Report: Emergency department use of a high-sensitivity point-of-care troponin assay reduces length of stay: an implementation study preliminary report
Pickering JW, et al.
2024 Article, Eur Heart J Acute Cardiovasc Care
The iCare Faster study is one of the first to document the real-world use of a high-sensitivity cardiac troponin I (hs-cTnI) test with a point-of-care (POC) device in the clinical process at Christchurch Hospital, a busy tertiary emergency department in New Zealand.
Analytical verification of the Atellica VTLi point of care high sensitivity troponin I assay
Florkowski et al.
2024 Article, Clin Chem Lab Med
This analytical verification of the Atellica VTLi hs-cTnI was carried out at Canterbury Health Laboratories, Christchurch Hospital, to support future clinical outcome studies (i-Care Faster) using existing validation data.
